XDH and chronic kidney disease: Nevertheless, the demonstration that treatment with xanthine oxidase inhibitors (XOIs) provides effective protection in the subgroup of CKD patients in the early phases of disease but not in more advanced stages [29–33] suggests the usefulness of detailed characterization of individuals who could benefit from urate lowering treatment.